Lawsuit Archives

Healthcare Industry News Weekly Wrap-Up: April 25, 2024

// Biotech and Pharma Therapeutics Bristol Myers taps startup to boost cell therapy production April 22, 2024 / Cell Therapy / CAR-T Therapies / Bristol Myers Squibb / Partnership Bristol Myers Squibb has partnered with Cellares, a California-based startup, to...

April 25, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: April 18, 2024

// Biotech and Pharma Therapeutics Lilly obesity drug shows benefit in sleep disorder study, pointing to new use April 17, 2024 / Eli Lilly / Obesity / Sleep Disorder / GLP-1 / Clinical Trials Fresh clinical trial results for Eli...

April 18, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: April 11, 2024

// Biotech and Pharma Therapeutics AACR 2024: Getting older younger may be driving rise in early-onset cancers April 8, 2024 / Cancer / AACR As with most common diseases of the developed world, aging is the major risk factor for...

April 11, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: April 5, 2024

// Biotech and Pharma Therapeutics Following Boehringer’s lead, AstraZeneca ⁠caps monthly out-of-pocket inhaler costs at $35 in the US March 18, 2024 / AstraZeneca / Symbicort / Inhaled Medicines / Asthma AstraZeneca on Monday revealed it’s expanding a savings program...

April 5, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: March 28, 2024

March 28, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: March 7, 2024

// Biotech and Pharma Therapeutics RSV vaccines may raise risk of Guillain-Barré syndrome, FDA preliminary analysis finds March 4, 2024 / RSV / Pfizer / GSK / Arexvy After decades of research into respiratory syncytial virus (RSV), Pfizer and GSK’s...

March 7, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: February 29, 2024

// Biotech and Pharma Therapeutics Boehringer Ingelheim’s Liver Drug Data Position It for MASH Clash With Eli Lilly February 26, 2024 / Boehringer Ingelheim / Liver / New Drug / MASH / Eli Lilly Preliminary Phase 2 results show 83%...

February 29, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: February 9, 2024

// Biotech and Pharma Therapeutics BridgeBio sells partial rights to dwarfism drug for $100M February 7, 2024 / BridgeBio / Kyowa Kirin / BioMarin Achondroplasia is the most common form of dwarfism and is caused by alterations to a gene...

February 9, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: January 26, 2024

// Biotech and Pharma Therapeutics Lilly gene therapy finding puts focus on hearing loss treatment pipeline January 24, 2024 / Eli Lilly / Gene Therapy / Drug Target / Hearing loss An 11-year-old boy who was born deaf can hear...

January 26, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: January 19, 2024

// Biotech and Pharma Therapeutics Kyverna sets plans for IPO in test of biotech enthusiasm January 17, 2024 / Kyverna / IPO / Startup More than two years after the bottom fell out for biotech stocks, the market for IPOs...

January 19, 2024

1 2 3 4

Tag: Lawsuit

Healthcare Industry News Weekly Wrap-Up: April 25, 2024

Healthcare Industry News Weekly Wrap-Up: April 18, 2024

Healthcare Industry News Weekly Wrap-Up: April 11, 2024

Healthcare Industry News Weekly Wrap-Up: April 5, 2024

Healthcare Industry News Weekly Wrap-Up: March 28, 2024

Healthcare Industry News Weekly Wrap-Up: March 7, 2024

Healthcare Industry News Weekly Wrap-Up: February 29, 2024

Healthcare Industry News Weekly Wrap-Up: February 9, 2024

Healthcare Industry News Weekly Wrap-Up: January 26, 2024

Healthcare Industry News Weekly Wrap-Up: January 19, 2024

Contact Us

Vault Bioventures HQ

Maximize Innovation

Strategic Clarity

Strategy⁺

About Vault

Tag: Lawsuit

Contact Us

Vault Bioventures HQ

Maximize Innovation

Strategic Clarity

Strategy+

About Vault

Strategy⁺